Andira Pharmaceuticals
PrivateLast Round
Seed
Sep 24, 2026
Total Funding Raised
$140,000
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Andira Pharmaceuticals operates in Healthcare & Life Sciences and is based in Vancouver. Its latest recorded funding round was an Early Funding round in October 2023.
Andira Pharmaceuticals is a biotechnology company that develops cannabinoid-based therapeutics and medical devices for infection control, post-surgical recovery, and breast cancer treatment.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Andira Pharmaceuticals Comparables
Compare Andira Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CNBX Pharmaceuticals Inc. | 77% | |
| ZYUS Life Sciences Corporation | 76% | |
| AmacaThera | 76% |
For institutional investors. Book with your work email.
Andira Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 24, 2026 | ||||
| Seed Round | Aug 4, 2026 | ||||
| Seed Round | Feb 26, 2026 | ||||
| Seed | Jun 27, 2024 | ||||
| Early Funding | Oct 25, 2023 | ||||
Grant | Mar 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Andira Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| US Capital Global Securities | Early Funding |
| Mitacs | Grant |
| First Fund | Seed Round, Seed |
| UBC Investment Management | Grant, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 24, 2026
$120K round completed.
- Aug 4, 2026
$100K Seed Round raised.
For institutional investors. Book with your work email.
Andira Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Andira Pharmaceuticals's valuation, stock price, and market status.
Is Andira Pharmaceuticals a public or private company?
Andira Pharmaceuticals is a private company.
What is the current stock price of Andira Pharmaceuticals?
Andira Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Andira Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Andira Pharmaceuticals worth (valuation)?
Valuation information for Andira Pharmaceuticals is not publicly available.
Can I buy Andira Pharmaceuticals stock?
Andira Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Andira Pharmaceuticals's last funding round?
Andira Pharmaceuticals's most recent funding round was Seed on September 24, 2026.
Who are the main investors in Andira Pharmaceuticals?
Key investors in Andira Pharmaceuticals include First Fund.
Will Andira Pharmaceuticals IPO soon?
No public IPO plans have been announced for Andira Pharmaceuticals.
How can I track Andira Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Andira Pharmaceuticals's shares on secondary markets.